-
1
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
2
-
-
0037031061
-
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
-
-
-
-
3
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
-
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun C-C, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335: 1001-1009.
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
Brown, L.7
Warnica, J.W.8
Arnold, J.M.O.9
Wun, C.-C.10
Davis, B.R.11
Braunwald, E.12
-
4
-
-
0033405389
-
Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction
-
Ueda Y, Kitakaze M, Komamura K, Minamino T, Asanuma H, Sato H, Kuzuya T, Takeda H, Hori M. Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. J Am Coll Cardiol. 1999;34:2120-2125.
-
(1999)
J Am Coll Cardiol
, vol.34
, pp. 2120-2125
-
-
Ueda, Y.1
Kitakaze, M.2
Komamura, K.3
Minamino, T.4
Asanuma, H.5
Sato, H.6
Kuzuya, T.7
Takeda, H.8
Hori, M.9
-
5
-
-
20844443811
-
Optimal windows of statin use for immediate infarct limitation: 5′-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase
-
Sanada S, Asanuma H, Minamino T, Node K, Takashima S, Okuda H, Shinozaki Y, Ogai A, Fujita M, Hirata A, Kim J, Asano Y, Mori H, Tomoike H, Kitamura S, Hori M, Kitakaze M. Optimal windows of statin use for immediate infarct limitation: 5′-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase. Circulation. 2004;110: 2143-2149.
-
(2004)
Circulation
, vol.110
, pp. 2143-2149
-
-
Sanada, S.1
Asanuma, H.2
Minamino, T.3
Node, K.4
Takashima, S.5
Okuda, H.6
Shinozaki, Y.7
Ogai, A.8
Fujita, M.9
Hirata, A.10
Kim, J.11
Asano, Y.12
Mori, H.13
Tomoike, H.14
Kitamura, S.15
Hori, M.16
Kitakaze, M.17
-
6
-
-
0037040861
-
Lovastatin enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: Implication of rho-family GTPases
-
Ledoux S, Laouari D, Essig M, Runembert I, Trugnan G, Michel JB, Friedlander G. Lovastatin enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases. Circ Res. 2002;90:420-427.
-
(2002)
Circ Res
, vol.90
, pp. 420-427
-
-
Ledoux, S.1
Laouari, D.2
Essig, M.3
Runembert, I.4
Trugnan, G.5
Michel, J.B.6
Friedlander, G.7
-
7
-
-
39749135567
-
Effect of adenosine A(2) receptor stimulation on platelet activation-aggregation: Differences between canine and human models
-
Linden MD, Barnard MR, Frelinger AL, Michelson AD, Przyklenk K. Effect of adenosine A(2) receptor stimulation on platelet activation-aggregation: Differences between canine and human models. Thromb Res. 2008;121:689-698.
-
(2008)
Thromb Res
, vol.121
, pp. 689-698
-
-
Linden, M.D.1
Barnard, M.R.2
Frelinger, A.L.3
Michelson, A.D.4
Przyklenk, K.5
-
8
-
-
33646456788
-
CD73/ecto-5′- nucleotidase protects against vascular inflammation and neointima formation
-
Zernecke A, Bidzhekov K, Ozuyaman B, Fraemohs L, Liehn EA, Luscher-Firzlaff JM, Luscher B, Schrader J, Weber C. CD73/ecto-5′- nucleotidase protects against vascular inflammation and neointima formation. Circulation. 2006;113:2120-2127.
-
(2006)
Circulation
, vol.113
, pp. 2120-2127
-
-
Zernecke, A.1
Bidzhekov, K.2
Ozuyaman, B.3
Fraemohs, L.4
Liehn, E.A.5
Luscher-Firzlaff, J.M.6
Luscher, B.7
Schrader, J.8
Weber, C.9
-
9
-
-
0034625177
-
Beneficial effects of intra-coronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction
-
Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intra-coronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000;101:2154-2159.
-
(2000)
Circulation
, vol.101
, pp. 2154-2159
-
-
Marzilli, M.1
Orsini, E.2
Marraccini, P.3
Testa, R.4
-
10
-
-
4944219936
-
Statin administration before percutaneous coronary intervention: Impact on periprocedural myocardial infarction
-
Briguori C, Colombo A, Airoldi F, Violante A, Focaccio A, Balestrieri P, Paolo EP, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Bonizzoni E, Ricciardelli B. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction. Eur Heart J. 2004;25:1822-1828.
-
(2004)
Eur Heart J
, vol.25
, pp. 1822-1828
-
-
Briguori, C.1
Colombo, A.2
Airoldi, F.3
Violante, A.4
Focaccio, A.5
Balestrieri, P.6
Paolo, E.P.7
Golia, B.8
Lepore, S.9
Riviezzo, G.10
Scarpato, P.11
Librera, M.12
Bonizzoni, E.13
Ricciardelli, B.14
-
11
-
-
4644324135
-
Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery
-
Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110:II45-II49.
-
(2004)
Circulation
, vol.110
-
-
Pan, W.1
Pintar, T.2
Anton, J.3
Lee, V.V.4
Vaughn, W.K.5
Collard, C.D.6
-
12
-
-
4043133008
-
Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study
-
Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di SG. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2004;110: 674-678.
-
(2004)
Circulation
, vol.110
, pp. 674-678
-
-
Pasceri, V.1
Patti, G.2
Nusca, A.3
Pristipino, C.4
Richichi, G.5
Di, S.G.6
-
13
-
-
1542376177
-
Glyburide inhibits dipyridamole-induced forearm vasodilation but not adenosine-induced forearm vasodilation
-
Bijlstra P, van Ginneken EEM, Huls M, van Dijk R, Smits P, Rongen GA. Glyburide inhibits dipyridamole-induced forearm vasodilation but not adenosine-induced forearm vasodilation. Clin Pharmacol Ther. 2004;75: 147-156.
-
(2004)
Clin Pharmacol Ther
, vol.75
, pp. 147-156
-
-
Bijlstra, P.1
van Ginneken, E.E.M.2
Huls, M.3
van Dijk, R.4
Smits, P.5
Rongen, G.A.6
-
14
-
-
40949094462
-
Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation
-
Meijer P, Wouters CW, van den Broek PH, Scheffer GJ, Riksen NP, Smits P, Rongen GA. Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation. Br J Pharmacol. 2008;153:1169-1176.
-
(2008)
Br J Pharmacol
, vol.153
, pp. 1169-1176
-
-
Meijer, P.1
Wouters, C.W.2
van den Broek, P.H.3
Scheffer, G.J.4
Riksen, N.P.5
Smits, P.6
Rongen, G.A.7
-
15
-
-
12344320991
-
Annexin A5 scintigraphy of forearm as a novel in-vivo model of skeletal muscle preconditioning in man
-
Rongen GA, Oyen WJG, Ramakers BP, Riksen NP, Boerman OC, Steinmetz N, Smits P. Annexin A5 scintigraphy of forearm as a novel in-vivo model of skeletal muscle preconditioning in man. Circulation. 2005;111:173-178.
-
(2005)
Circulation
, vol.111
, pp. 173-178
-
-
Rongen, G.A.1
Oyen, W.J.G.2
Ramakers, B.P.3
Riksen, N.P.4
Boerman, O.C.5
Steinmetz, N.6
Smits, P.7
-
16
-
-
33746813097
-
Caffeine prevents protection in two human models of ischemic preconditioning
-
Riksen NP, Zhou Z, Oyen WJ, Jaspers R, Ramakers BP, Brouwer RM, Boerman OC, Steinmetz N, Smits P, Rongen GA. Caffeine prevents protection in two human models of ischemic preconditioning. J Am Coll Cardiol. 2006;48:700-707.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 700-707
-
-
Riksen, N.P.1
Zhou, Z.2
Oyen, W.J.3
Jaspers, R.4
Ramakers, B.P.5
Brouwer, R.M.6
Boerman, O.C.7
Steinmetz, N.8
Smits, P.9
Rongen, G.A.10
-
17
-
-
0033603823
-
Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death
-
Hammill AK, Uhr JW, Scheuermann RH. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res. 1999;251:16-21.
-
(1999)
Exp Cell Res
, vol.251
, pp. 16-21
-
-
Hammill, A.K.1
Uhr, J.W.2
Scheuermann, R.H.3
-
18
-
-
0027989808
-
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis
-
Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84: 1415-1420.
-
(1994)
Blood
, vol.84
, pp. 1415-1420
-
-
Koopman, G.1
Reutelingsperger, C.P.2
Kuijten, G.A.3
Keehnen, R.M.4
Pals, S.T.5
van Oers, M.H.6
-
19
-
-
35248886071
-
-
Shen XD, Ke B, Zhai Y, Tsuchihashi SI, Gao F, Duarte S, Coito A, Busuttil RW, Allison AC, Kupiec-Weglinski JW. Diannexin, a novel annexin V homodimer, protects rat liver transplants against cold ischemia-reperfusion injury. Am J Transplant. 2007;7:2463-2471.
-
Shen XD, Ke B, Zhai Y, Tsuchihashi SI, Gao F, Duarte S, Coito A, Busuttil RW, Allison AC, Kupiec-Weglinski JW. Diannexin, a novel annexin V homodimer, protects rat liver transplants against cold ischemia-reperfusion injury. Am J Transplant. 2007;7:2463-2471.
-
-
-
-
20
-
-
34547529790
-
-
Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK, McCuskey RS, Farrell GC, Allison AC. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology. 2007;133:632-646.
-
Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK, McCuskey RS, Farrell GC, Allison AC. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology. 2007;133:632-646.
-
-
-
-
21
-
-
0029967435
-
Simultaneous high-performance liquid chromatographic determination of caffeine and theophylline for routine drug monitoring in human plasma
-
Schreiber-Deturmeny E, Bruguerolle B. Simultaneous high-performance liquid chromatographic determination of caffeine and theophylline for routine drug monitoring in human plasma. J Chromatogr B Biomed Appl. 1996;677:305-312.
-
(1996)
J Chromatogr B Biomed Appl
, vol.677
, pp. 305-312
-
-
Schreiber-Deturmeny, E.1
Bruguerolle, B.2
-
22
-
-
0033586693
-
Quantification of extra-cellular and intracellular adenosine production: Understanding the transmembranous concentration gradient
-
Deussen A, Stappert M, Schafer S, Kelm M. Quantification of extra-cellular and intracellular adenosine production: understanding the transmembranous concentration gradient. Circulation. 1999;99:2041-2047.
-
(1999)
Circulation
, vol.99
, pp. 2041-2047
-
-
Deussen, A.1
Stappert, M.2
Schafer, S.3
Kelm, M.4
-
23
-
-
0027366776
-
Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart
-
Kroll K, Decking UK, Dreikorn K, Schrader J. Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart. Circ Res. 1993; 73:846-856.
-
(1993)
Circ Res
, vol.73
, pp. 846-856
-
-
Kroll, K.1
Decking, U.K.2
Dreikorn, K.3
Schrader, J.4
-
24
-
-
21844439777
-
Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans
-
Riksen NP, Oyen WJ, ramakers BP, van den Broek PH, Engbersen R, Boerman OC, Smits P, Rongen GA. Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans. Clin Pharmacol Ther. 2005;78:52-59.
-
(2005)
Clin Pharmacol Ther
, vol.78
, pp. 52-59
-
-
Riksen, N.P.1
Oyen, W.J.2
ramakers, B.P.3
van den4
Broek, P.H.5
Engbersen, R.6
Boerman, O.C.7
Smits, P.8
Rongen, G.A.9
-
25
-
-
23044469024
-
In vivo evidence against a role for adenosine in the exercise pressor reflex in humans
-
Riksen NP, van Ginneken EE, van den Broek PH, Smits P, Rongen GA. In vivo evidence against a role for adenosine in the exercise pressor reflex in humans. J Appl Physiol. 2005;99:522-527.
-
(2005)
J Appl Physiol
, vol.99
, pp. 522-527
-
-
Riksen, N.P.1
van Ginneken, E.E.2
van den Broek, P.H.3
Smits, P.4
Rongen, G.A.5
-
26
-
-
0035983919
-
Diadenosine penta-phosphate vasodilates the forearm vascular bed: Inhibition by theophylline and augmentation by dipyridamole
-
van Ginneken EE, Rongen GA, Russel FG, Smits P. Diadenosine penta-phosphate vasodilates the forearm vascular bed: Inhibition by theophylline and augmentation by dipyridamole. Clin Pharmacol Ther. 2002; 71:448-456.
-
(2002)
Clin Pharmacol Ther
, vol.71
, pp. 448-456
-
-
van Ginneken, E.E.1
Rongen, G.A.2
Russel, F.G.3
Smits, P.4
-
27
-
-
33947517527
-
Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: Results of the ARMYDA-ACS randomized trial
-
Patti G, Pasceri V, Colonna G, Miglionico M, Fischetti D, Sardella G, Montinaro A, Di SG. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol. 2007;49:1272-1278.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1272-1278
-
-
Patti, G.1
Pasceri, V.2
Colonna, G.3
Miglionico, M.4
Fischetti, D.5
Sardella, G.6
Montinaro, A.7
Di, S.G.8
-
28
-
-
0035941786
-
Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial
-
Smilde TJ, van WS, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet. 2001;357:577-581.
-
(2001)
Lancet
, vol.357
, pp. 577-581
-
-
Smilde, T.V.W.1
Wollersheim, H.2
Trip, M.D.3
Kastelein, J.J.4
Stalenhoef, A.F.5
-
29
-
-
41649107358
-
Simvastatin with or without ezetimibe in familial hypercholesterolemia
-
Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de GE. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358: 1431-1443.
-
(2008)
N Engl J Med
, vol.358
, pp. 1431-1443
-
-
Kastelein, J.J.1
Akdim, F.2
Stroes, E.S.3
Zwinderman, A.H.4
Bots, M.L.5
Stalenhoef, A.F.6
Visseren, F.L.7
Sijbrands, E.J.8
Trip, M.D.9
Stein, E.A.10
Gaudet, D.11
Duivenvoorden, R.12
Veltri, E.P.13
Marais, A.D.14
de, G.E.15
-
30
-
-
34249082811
-
Statins: Multiple mechanisms of action in the ischemic brain
-
Cimino M, Gelosa P, Gianella A, Nobili E, Tremoli E, Sironi L. Statins: multiple mechanisms of action in the ischemic brain. Neuroscientist. 2007;13:208-213.
-
(2007)
Neuroscientist
, vol.13
, pp. 208-213
-
-
Cimino, M.1
Gelosa, P.2
Gianella, A.3
Nobili, E.4
Tremoli, E.5
Sironi, L.6
-
31
-
-
34447517167
-
Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation
-
Bulhak A, Roy J, Hedin U, Sjoquist PO, Pernow J. Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation. Am J Physiol Heart Circ Physiol. 2007;292:H3158-H3163.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
-
-
Bulhak, A.1
Roy, J.2
Hedin, U.3
Sjoquist, P.O.4
Pernow, J.5
-
32
-
-
49749108198
-
Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway
-
Sharyo S, Yokota-Ikeda N, Mori M, Kumagai K, Uchida K, Ito K, Burne-Taney MJ, Rabb H, Ikeda M. Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int. 2008;74:577-584.
-
(2008)
Kidney Int
, vol.74
, pp. 577-584
-
-
Sharyo, S.1
Yokota-Ikeda, N.2
Mori, M.3
Kumagai, K.4
Uchida, K.5
Ito, K.6
Burne-Taney, M.J.7
Rabb, H.8
Ikeda, M.9
-
33
-
-
0026047960
-
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart
-
Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-356.
-
(1991)
Circulation
, vol.84
, pp. 350-356
-
-
Liu, G.S.1
Thornton, J.2
Van Winkle, D.M.3
Stanley, A.W.4
Olsson, R.A.5
Downey, J.M.6
-
34
-
-
85047678041
-
Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart
-
Liu GS, Richards SC, Olsson RA, Mullane K, Walsh RS, Downey JM. Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res. 1994;28:1057-1061.
-
(1994)
Cardiovasc Res
, vol.28
, pp. 1057-1061
-
-
Liu, G.S.1
Richards, S.C.2
Olsson, R.A.3
Mullane, K.4
Walsh, R.S.5
Downey, J.M.6
-
35
-
-
0022970945
-
Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
-
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74:1124-1136.
-
(1986)
Circulation
, vol.74
, pp. 1124-1136
-
-
Murry, C.E.1
Jennings, R.B.2
Reimer, K.A.3
-
36
-
-
0345561561
-
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use
-
Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51:83-133.
-
(1999)
Pharmacol Rev
, vol.51
, pp. 83-133
-
-
Fredholm, B.B.1
Battig, K.2
Holmen, J.3
Nehlig, A.4
Zvartau, E.E.5
-
37
-
-
0021933147
-
The cardiovascular effects of regular and decaffeinated coffee
-
Smits P, Thien T, van't Laar A. The cardiovascular effects of regular and decaffeinated coffee. Br J Clin Pharmacol. 1985;19:852-854.
-
(1985)
Br J Clin Pharmacol
, vol.19
, pp. 852-854
-
-
Smits, P.1
Thien, T.2
van't Laar, A.3
-
38
-
-
48349147462
-
Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins against Ischemia-Reperfusion Injury in the Rat
-
Ye Y, bu Said GH, Lin Y, Manickavasagam S, Hughes MG, McAdoo DJ, Perez-Polo RJ, Birnbaum Y. Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins against Ischemia-Reperfusion Injury in the Rat. Cardiovasc Drugs Ther. 2008;22:275-282.
-
(2008)
Cardiovasc Drugs Ther
, vol.22
, pp. 275-282
-
-
Ye, Y.1
bu Said, G.H.2
Lin, Y.3
Manickavasagam, S.4
Hughes, M.G.5
McAdoo, D.J.6
Perez-Polo, R.J.7
Birnbaum, Y.8
-
39
-
-
34447499108
-
Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination
-
Ye Y, Lin Y, Perez-Polo R, Huang MH, Hughes MG, McAdoo DJ, Manickavasagam S, Uretsky BF, Birnbaum Y. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination. Am J Physiol Heart Circ Physiol. 2007;293: H813-H818.
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.293
-
-
Ye, Y.1
Lin, Y.2
Perez-Polo, R.3
Huang, M.H.4
Hughes, M.G.5
McAdoo, D.J.6
Manickavasagam, S.7
Uretsky, B.F.8
Birnbaum, Y.9
-
40
-
-
33644792595
-
CYP1A2 genotype, and risk of myocardial infarction
-
Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006;295: 1135-1141.
-
(2006)
JAMA
, vol.295
, pp. 1135-1141
-
-
Cornelis, M.C.1
El-Sohemy, A.2
Kabagambe, E.K.3
Campos, H.4
Coffee5
|